Cargando…

Eculizumab in the treatment of neuromyelitis optica spectrum disorder

Detalles Bibliográficos
Autores principales:	Nabizadeh, Fardin, Moghadasi, Abdorreza Naser
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2023
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460925/ https://www.ncbi.nlm.nih.gov/pubmed/38011413 http://dx.doi.org/10.18502/cjn.v22i2.13342

Ejemplares similares

Association of cigarette smoking with neuromyelitis optica-immunoglobulin G sero-positivity in neuromyelitis optica spectrum disorder
por: Eskandarieh, Sharareh, et al.
Publicado: (2019)

Increased Intracranial Pressure on a Patient with Neuromyelitis Optica Spectrum Disorder
por: Forouzannia, Seyed Mohammad, et al.
Publicado: (2021)

Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
por: Frampton, James E.
Publicado: (2020)

Whole grains and legumes consumption in association with neuromyelitis optica spectrum disorder odds
por: Rezaeimanesh, Nasim, et al.
Publicado: (2021)

Correction to: Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
por: Frampton, James E.
Publicado: (2020)

Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Neuromyelitis Optica Spectrum Disorder
por: Singh, Pratap, et al.
Publicado: (2021)

Disability and Therapeutic Response in Paediatric Neuromyelitis Optica Spectrum Disorder: A Case Series from Iran
por: BAGHBANIAN, Seyed Mohammad, et al.
Publicado: (2019)

Neuromyelitis Optica Spectrum Disorder Presenting with Pseudoathetosis
por: Seok, Hung Youl, et al.
Publicado: (2018)

COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica
por: Cabal-Herrera, Ana Maria, et al.
Publicado: (2021)

Eculizumab for acute relapse of neuromyelitis optica spectrum disorder: Case report
por: Chatterton, Sophie, et al.
Publicado: (2022)

Efficacy and safety of rituximab in patients with refractory neuromyelitis optica spectrum disorders: A prospective observation in Iranian cases
por: Seyed Ahadi, Maral, et al.
Publicado: (2020)

Prevalence of COVID-19 infection in patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2021)

Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder
por: Maghbooli, Zhila, et al.
Publicado: (2021)

Adding erythropoietin to intravenous methylprednisolone in acute treatment of attacks of neuromyelitis optica spectrum disorders: A randomized controlled trial
por: Shafaei, Maryam, et al.
Publicado: (2022)

CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder
por: Namatame, Chihiro, et al.
Publicado: (2021)

Watch out for neuromyelitis optica spectrum disorder onset or clinical relapse after COVID-19 vaccination: What neurologists need to know?
por: Paybast, Sepideh, et al.
Publicado: (2022)

The association between body mass index, demographic and clinical characteristics with cognitive performance in patients with neuromyelitis optica spectrum disorder
por: Rezaeimanesh, Nasim, et al.
Publicado: (2022)

Neuromyelitis Optica Spectrum Disorder in a Patient with Ankylosing Spondylitis
por: Jeong, Soo, et al.
Publicado: (2018)

Neuromyelitis Optica Spectrum Disorder with Vertical Gaze Palsy and Hypersomnolence
por: Mathew, Jomal, et al.
Publicado: (2019)

Subacute Myelopathy: Think Beyond Neuromyelitis Optica Spectrum Disorder
por: Kasinathan, Ananthanarayanan, et al.
Publicado: (2019)

Cortical Blindness: An Unusual Manifestation of Neuromyelitis Optica Spectrum Disorder
por: Reddy Nagireddy, Ram Bhupal, et al.
Publicado: (2022)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Eculizumab in the Treatment of Aquaporin-4 Seronegative Neuromyelitis Optica Spectrum Disorder: A Case Report
por: Digala, Lakshmi, et al.
Publicado: (2021)

Convergence spasm due to aquaporin-positive neuromyelitis optica spectrum disorder
por: Özçelik, Pınar, et al.
Publicado: (2017)

Recurrent hiccups in COVID-19 forme fruste of neuromyelitis optica spectrum disorder?
por: Shubhakaran, Khichar P.
Publicado: (2022)

Treatment of Neuromyelitis Optica Spectrum Disorders
por: Chan, Koon-Ho, et al.
Publicado: (2021)

Pregnancy outcome in patients with neuromyelitis optica spectrum disorder treated with rituximab: A case-series study
por: Seyed Ahadi, Maral, et al.
Publicado: (2021)

Moyamoya disease presenting as thalamic infarction in a patient with neuromyelitis optica spectrum disorder
por: Zhang, Yin‐Xi, et al.
Publicado: (2019)

Seronegative neuromyelitis optica spectrum disorder in primary familial brain calcification with PDGFB variant
por: Biyajima, Masahiro, et al.
Publicado: (2022)

Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023)

Persistent Hyperthermia in a Patient with Aquaporin-4-Antibody-Positive Neuromyelitis Optica Spectrum Disorder
por: Hsu, Chia-Lun, et al.
Publicado: (2016)

Relapse After Cessation of Immunosuppressants in Seropositive Neuromyelitis Optica Spectrum Disorder With Long-Term Remission
por: Seok, Jin Myoung, et al.
Publicado: (2021)

Aquaporin 4 antibody‐positive neuromyelitis optica spectrum disorder with cholangiocarcinoma: Casual or causal association?
por: Fang, Wei, et al.
Publicado: (2022)

Eculizumab‐related drug reaction in a patient with neuromyelitis optica
por: Sharma, Rishi, et al.
Publicado: (2023)

Emerging treatments for neuromyelitis optica spectrum disorder
por: Wynford-Thomas, Ray, et al.
Publicado: (2020)

Neuromyelitis optica with linear enhancement of corpus callosum in brain magnetic resonance imaging with contrast: a case report
por: Sahraian, Mohammad Ali, et al.
Publicado: (2015)

Neuromyelitis optica spectrum disorders: An update
por: Pandit, Lekha
Publicado: (2015)

Satralizumab for neuromyelitis optica spectrum disorder
Publicado: (2021)

A Little-Known Brain Imaging Feature in Neuromyelitis Optica Spectrum Disorder: A Leukodystrophy-Like Pattern
por: Lee, Jun Seok, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_64j483frhjq4sbv5g4icjo9oet